Skip to search.
 FTSE 100 Down 1.03%

Sangamo Biosciences Inc. (SGMO)

-NasdaqGS
13.11 Down 0.23(1.72%) 19:15 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:13.34
Open:13.36
Bid:13.22 x 100
Ask:13.25 x 200
1y Target Est:24.20
Beta:2.59
Earnings Date:21 Jul - 27 Jul (Est.)
Day's Range:12.70 - 13.73
52wk Range:9.39 - 19.25
Volume:593,435
Avg Vol (3m):842,761
Market Cap:906.82m
P/E (ttm):N/A
EPS (ttm):-0.36
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SGMODown 1.72%906.82m
AMGNUp 0.51%124.04b
LLYUp 0.28%75.39b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.53
Quarterly EPS Est (Jun-15) :-0.13
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of engineered DNA-binding proteins as novel therapeutic products for unmet medical needs in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback